Search research articles
Contact Us
Filters
Showing results (1-10 of 175) with videos related to
Page
of 18
Sort By:
Drugs
|
February 1, 2011
Bacteraemic pneumococcal pneumonia: current therapeutic options
Charles Feldman, Ronald Anderson
Chest
|
May 8, 2015
Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies
Charles Feldman, Ronald Anderson
Respirology (Carlton, Vic.)
|
March 16, 2017
Cardiac troponin T as a predictor of short- and long-term mortality in community-acquired pneumonia
Charles Feldman, Ronald Anderson
Clinics in Chest Medicine
|
January 31, 2025
Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia
Charles Feldman, Ronald Anderson
Current Opinion in Critical Care
|
September 2, 2016
Community-acquired pneumonia: still a major burden of disease
Charles Feldman, Ronald Anderson
Frontiers in Immunology
|
October 12, 2020
Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia
Charles Feldman, Ronald Anderson
International Journal of Molecular Sciences
|
July 14, 2023
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy
Ronald Anderson, Charles Feldman
F1000Prime Reports
|
October 25, 2014
Recent advances in our understanding of Streptococcus pneumoniae infection
Charles Feldman, Ronald Anderson
The Journal of Infection
|
September 26, 2017
Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia
Ronald Anderson, Charles Feldman
Future Microbiology
|
July 31, 2007
Controversies in the treatment of pneumococcal community-acquired pneumonia
Charles Feldman, Ronald Anderson
Page
of 18
Search research articles
Search
Showing results (1-10 of 175) with videos related to
Sort By:
Page
of 18
Drugs
|
February 1, 2011
Bacteraemic pneumococcal pneumonia: current therapeutic options
Charles Feldman, Ronald Anderson
Chest
|
May 8, 2015
Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies
Charles Feldman, Ronald Anderson
Respirology (Carlton, Vic.)
|
March 16, 2017
Cardiac troponin T as a predictor of short- and long-term mortality in community-acquired pneumonia
Charles Feldman, Ronald Anderson
Clinics in Chest Medicine
|
January 31, 2025
Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia
Charles Feldman, Ronald Anderson
Current Opinion in Critical Care
|
September 2, 2016
Community-acquired pneumonia: still a major burden of disease
Charles Feldman, Ronald Anderson
Frontiers in Immunology
|
October 12, 2020
Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia
Charles Feldman, Ronald Anderson
International Journal of Molecular Sciences
|
July 14, 2023
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy
Ronald Anderson, Charles Feldman
F1000Prime Reports
|
October 25, 2014
Recent advances in our understanding of Streptococcus pneumoniae infection
Charles Feldman, Ronald Anderson
The Journal of Infection
|
September 26, 2017
Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia
Ronald Anderson, Charles Feldman
Future Microbiology
|
July 31, 2007
Controversies in the treatment of pneumococcal community-acquired pneumonia
Charles Feldman, Ronald Anderson
Page
of 18